Neurology News

AUSTIN, Texas — Long-term use of eptinezumab resulted in improvements in symptoms and headache days in patients with chronic migraine and medication-overuse headache, according to a poster presented here.

Interatrial block was associated with elevated risk for stroke and other poor outcomes in patients with no history of atrial fibrillation, according to a retrospective study.

AUSTIN, Texas — Sustained freedom from pain and the most bothersome migraine symptom was achieved in more patients treated with investigational STS 101 compared with placebo, according to a study presented here.

The FDA has approved Elevidys, a recombinant gene therapy for pediatric patients with Duchenne muscular dystrophy and confirmed gene mutation who do not have a pre-existing medical reason preventing treatment.

AUSTIN, Texas — Atogepant significantly improved daily functioning and reduced physical impairment in adults with chronic migraine within 1 week of treatment, according to study results presented here by Jessica Ailani, MD.

INDIANAPOLIS — Sleep duration, latencies and loneliness were associated with problematic drinking among college students with and without substance use disorder in 2020.

AUSTIN, Texas — In-clinic administration of IV ketamine significantly improved refractory chronic migraine pain intensity in a small cohort of patients, according to a poster presented here.

Halozyme Therapeutics announced that argenx received FDA approval for Vyvgart Hytrulo with Enhanze for subcutaneous use in adults with generalized myasthenia gravis who are anti-acetylcholine receptor antibody positive.

Cincinnati Children’s Hospital Medical Center was ranked No. 1 on the U.S. News & World Report’s list of best children’s hospitals for the first time.

Patients with knee osteoarthritis who experience sleep disturbances are more likely to experience catastrophizing and worsened knee pain, according to data published in Arthritis Care & Research.